These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28267649)

  • 1. Intravitreal injection of anti-Interleukin (IL)-6 antibody attenuates experimental autoimmune uveitis in mice.
    Tode J; Richert E; Koinzer S; Klettner A; Pickhinke U; Garbers C; Rose-John S; Nölle B; Roider J
    Cytokine; 2017 Aug; 96():8-15. PubMed ID: 28267649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
    Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis.
    Qin T
    Mol Vis; 2011; 17():3486-93. PubMed ID: 22219644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
    Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
    Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
    Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
    Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis.
    Lee DJ; Biros DJ; Taylor AW
    Int Immunopharmacol; 2009 Aug; 9(9):1079-86. PubMed ID: 19426838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
    Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody.
    Ishida W; Fukuda K; Sakamoto S; Koyama N; Koyanagi A; Yagita H; Fukushima A
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8224-30. PubMed ID: 21896864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of systemic and intravitreal TNF-α inhibition in experimental autoimmune uveoretinitis.
    Busch M; Bauer D; Hennig M; Wasmuth S; Thanos S; Heiligenhaus A
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):39-46. PubMed ID: 23211816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-IRBP IgG1 and IgG2a response does not correlate with susceptibility to experimental autoimmune uveitis.
    de Moraes LV; Martins GA; Flangini M; Ibañez OM; Sant'Anna OA; Rizzo LV
    Braz J Med Biol Res; 2006 Jun; 39(6):773-83. PubMed ID: 16751983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells.
    Bing SJ; Lyu C; Xu B; Wandu WS; Hinshaw SJ; Furumoto Y; Caspi RR; Gadina M; Gery I
    Mol Vis; 2020; 26():641-651. PubMed ID: 33088168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of exogenous interleukin-2, interleukin-23 on differentiation of IRBP 1-20-specific T cells toward Th1 and Th17 and comparison of the pathogenicity of IRBP 1-20-specific T cells].
    Li Y; Cui Y; Bi HS; Wang Y; Li J; Wang XR
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):224-9. PubMed ID: 23866703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.
    Yang H; Zheng S; Mao Y; Chen Z; Zheng C; Li H; Sumners C; Li Q; Yang P; Lei B
    Clin Exp Immunol; 2016 Feb; 183(2):280-93. PubMed ID: 26400205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
    Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
    Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of experimental autoimmune uveoretinitis by Anti-IL-17 antibody.
    Zhang R; Qian J; Guo J; Yuan YF; Xue K
    Curr Eye Res; 2009 Apr; 34(4):297-303. PubMed ID: 19373578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD40 monoclonal antibody ameliorates experimental autoimmune uveoretinitis in mice.
    Xu L; Gao J; Pan Y; Tian N; He M; Jin L; Chen F
    Vet Ophthalmol; 2020 Sep; 23(5):797-805. PubMed ID: 32618114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated IL-21 and IL-21 receptor expression is involved in experimental autoimmune uveitis (EAU).
    Liu L; Xu Y; Wang J; Li H
    Mol Vis; 2009 Dec; 15():2938-44. PubMed ID: 20057909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.
    Yoshimura T; Sonoda KH; Ohguro N; Ohsugi Y; Ishibashi T; Cua DJ; Kobayashi T; Yoshida H; Yoshimura A
    Rheumatology (Oxford); 2009 Apr; 48(4):347-54. PubMed ID: 19164426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis.
    Keino H; Watanabe T; Sato Y; Niikura M; Wada Y; Okada AA
    Arthritis Res Ther; 2008; 10(5):R122. PubMed ID: 18847496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.